Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients.

@article{Shermock2005NumberNT,
  title={Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients.},
  author={Kenneth M. Shermock and Ed Horn and Pamela A. Lipsett and Peter J. Pronovost and Todd Dorman},
  journal={Critical care medicine},
  year={2005},
  volume={33 3},
  pages={497-503}
}
OBJECTIVE To calculate the absolute risk reduction of transfusion-related adverse events, the number of patients needed to treat, and cost to avoid one transfusion-related adverse event by using erythropoietin in critically ill patients DESIGN Number needed to treat with sensitivity analysis. SETTING Teaching hospital. PATIENTS Hypothetical cohort of critically ill patients who were candidates to receive erythropoietin. INTERVENTIONS Using vs. not using erythropoietin to reduce the need… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 56 references

Similar Papers

Loading similar papers…